Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 5
2005 4
2006 6
2007 5
2008 3
2009 1
2010 5
2011 4
2012 9
2013 10
2014 7
2015 7
2016 4
2017 8
2018 6
2019 7
2020 8
2021 9
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Ultra-hyper-fractionated radiotherapy for high-grade gliomas.
Frosina G, Fontana V, Verzola D, Rosa A, Gaggero G, Garibotto G, Vagge S, Pigozzi S, Daga A. Frosina G, et al. Among authors: fontana v. J Neurosci Res. 2021 Dec;99(12):3182-3203. doi: 10.1002/jnr.24929. Epub 2021 Nov 8. J Neurosci Res. 2021. PMID: 34747065
HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk.
Bonaccorsi I, Carrega P, Venanzi Rullo E, Ducatelli R, Falco M, Freni J, Miceli M, Cavaliere R, Fontana V, Versace A, Caramori G, David A, Nunnari G, Ferlazzo G. Bonaccorsi I, et al. Among authors: fontana v. Immunol Lett. 2021 Jun;234:44-46. doi: 10.1016/j.imlet.2021.04.007. Epub 2021 Apr 24. Immunol Lett. 2021. PMID: 33905752 Free PMC article. No abstract available.
Can pan-allergens affect the sensitization pattern?
Ciprandi G, Comite P, Bruzzone M, Fontana V. Ciprandi G, et al. Among authors: fontana v. Immunobiology. 2017 May;222(5):726-729. doi: 10.1016/j.imbio.2017.01.006. Epub 2017 Jan 28. Immunobiology. 2017. PMID: 28159395
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
Coco S, Boccardo S, Mora M, Fontana V, Vanni I, Genova C, Alama A, Salvi S, Dal Bello MG, Bonfiglio S, Rijavec E, Sini C, Barletta G, Biello F, Carli F, Cavalieri Z, Burrafato G, Longo L, Ballestrero A, Grossi F. Coco S, et al. Among authors: fontana v. Clin Breast Cancer. 2021 Jun;21(3):218-230.e6. doi: 10.1016/j.clbc.2020.09.001. Epub 2020 Sep 6. Clin Breast Cancer. 2021. PMID: 33008754
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis.
Carosio R, Fontana V, Mastracci L, Ferro P, Grillo F, Banelli B, Canessa PA, Dessanti P, Vigani A, Morabito A, Pfeffer U, Poggi A, Roncella S, Pistillo MP. Carosio R, et al. Among authors: fontana v. J Cancer Res Clin Oncol. 2021 Feb;147(2):459-468. doi: 10.1007/s00432-020-03457-7. Epub 2020 Nov 20. J Cancer Res Clin Oncol. 2021. PMID: 33216211
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score.
Grosso F, Mannucci M, Ugo F, Ferro P, Cassinari M, Vigani A, De Angelis AM, Delfanti S, Lia M, Guaschino R, Barbero S, Roncella S, Giannoni U, Bertolotti M, Pistillo MP, Fontana V. Grosso F, et al. Among authors: fontana v. Diagnostics (Basel). 2021 Oct 29;11(11):2015. doi: 10.3390/diagnostics11112015. Diagnostics (Basel). 2021. PMID: 34829362 Free PMC article.
95 results